^
AML Express assay is a next-generation sequencing (NGS) assay using combined DNA and RNA sequencing, which is used to identify prognostically and diagnostically informative alterations in acute myeloid leukemia (AML). The DNA sequencing component of this assay detects single nucleotide variants (SNVs) and indels in genes recurrently mutated in AML, and the RNA sequencing component detects fusions involving genes that are frequently involved in structural rearrangements observed in AML, as noted below.
Cancer:
Acute Myelogenous Leukemia
Gene:
ABL1 (ABL proto-oncogene 1), ASXL1 (ASXL Transcriptional Regulator 1), BCOR (BCL6 Corepressor), BRAF (B-raf proto-oncogene), CALR (Calreticulin), CBL (Cbl proto-oncogene)
See More ...
Method:
Next-Generation Sequencing